ASML: The Blowout Quarter the Market Sold — And Why That's the Opportunity

Prices as of ~12:00 PM ET, July 15, 2026. ASML US ADR $1,760.04 (−0.88% intraday; CNBC reports the Amsterdam line closing −0.49% after opening +7%). Q2 figures from ASML's official press release and earnings call transcript; consensus from LSEG.

1. What ASML Is — and Why It's Unlike Anything Else in Tech

ASML is not a chipmaker. It is the company that makes the machines that make the most advanced chips. It holds a 100% monopoly on extreme ultraviolet (EUV) lithography — the only tool on Earth capable of printing the sub-5nm transistors inside every leading-edge AI accelerator, whether that silicon is designed by Nvidia, AMD, Apple or Google and fabricated by TSMC, Samsung, Intel or SK Hynix. As CNBC put it plainly, "you can't make AI chips without ASML's EUV machines."

That gives ASML a structurally superior position to almost every name in the AI trade: it is agnostic to which chipmaker wins. Whether the memory war is won by Micron, Samsung or SK Hynix — whether Nvidia or a custom-ASIC rival takes accelerator share — every one of them must buy ASML's tools to compete. A low-NA EUV system sells for ~€215M; a High-NA system for ~€450M. There is no second supplier.

Key stats (as of today): market cap ~$588B (Europe's most valuable company), trailing P/E ~57x, ROE 44.7%, gross margin 51.8% TTM (54% in Q2), beta 2.27. The stock is up ~115% year-to-date and roughly 3x off its August 2025 low near $588.

2. The Catalyst: Q2 2026 — A Beat on Every Line, and a Big Guidance Raise

Reported before the bell July 15 (ASML Q2 2026 press release):

Lead with the guidance, not the beat. ASML raised full-year 2026 guidance for the second time this year:

• FY2026 revenue: €43–45B, up from €36–40B set in April (which itself was up from €34–39B).
• FY2026 gross margin: 54–56%, up from 51–53%.
• Q3 2026 guide: ~€11.5B in net sales — a ~23% sequential jump, signaling the back half accelerates, not fades.

On the call, CEO Christophe Fouquet said order intake was "extremely strong" in the first half as customers "accelerate their capacity expansion plans," giving ASML "increased visibility into longer-term demand" (Q2 2026 earnings call transcript). Management is adding 30% to its 2026 low-NA EUV capacity and 30% to DUV immersion capacity for 2027, and is investigating further increases for 2028. Read that again: the supply constraint is on ASML's side, not demand's.

A quieter but important milestone from the release: Intel has moved ASML's next-generation High-NA EUV into commercial chip production. High-NA adoption was the single biggest technical overhang on the long-term story; a marquee customer putting it into production de-risks the 2027–2030 roadmap.

One structural note for readers modeling the stock: ASML no longer discloses quarterly net bookings. The market's favorite single-quarter sentiment gauge is gone, which mechanically raises the weight of management's qualitative order commentary and the guide itself. Ironically, that removes the very metric that has whipsawed the stock on prior prints.

3. The Divergence: Why a Blowout Closed Red

Here is the interesting part, and the reason this is worth writing about today. ASML opened +7%, faded through the session, and closed slightly negative. Meanwhile the broader semiconductor complex was hammered on the very same day: Micron −8.2% ($902), AMD −5.5% ($518), the SMH semis ETF −3.1%, Nvidia −1.5%, TSMC −0.9% — even as the S&P and Dow finished green on soft inflation data (June PPI −0.3% MoM). Three forces are at work:

1. Valuation, priced for perfection. Morningstar's Javier Correonero told CNBC the stock trades at "roughly a 50x forward P/E, in line with the peaks we saw during Covid," versus his fair-value multiple of "more like 35–40x forward… we see it slightly overvalued." At that multiple, a beat-and-raise meets the bar rather than clearing it — there's little room for any execution slip (valuation breakdown).
2. A memory-supply scare that has nothing to do with ASML. SK Hynix's $26.5B Nasdaq debut (ticker SKHY) round-tripped from a +14% pop to a ~15% Seoul plunge on a weak HBM4 capacity-expansion read, reigniting fears that new, well-capitalized memory supply compresses DRAM/HBM pricing power (memory selloff coverage). That is a Micron/Samsung/SK Hynix pricing problem — ASML sells equipment to all of them and benefits from more capex regardless of who wins the pricing war.
3. Profit-taking after a +115% YTD run. The raise was partly telegraphed (ASML pre-announced the April raise; TSMC's +68% June sales and UBS's July 10 note had set expectations high). "Buy the rumor, sell the news" is ASML's recurring post-earnings pattern — it fell 10.5% on a Q2 beat in July 2025 and 6% on a beat-and-raise in April 2026.

Jim Cramer nailed the tell in his Wednesday note: "The positive action in the stock reflects the market's mood today more than it reflects ASML's performance. It's been fabulous for years." (CNBC)

My read: The fundamental print was an unambiguous green light for the durability of AI capex — capacity being added, not cut; visibility extending, not shrinking. The red close is a market-structure event (positioning + a memory-specific scare), not a demand event. When the fundamentals and the tape disagree this cleanly, I follow the fundamentals — and use the tape's fear to get paid a better entry.

4. Financials & Valuation — Earning the Premium, But Not Infinitely

The bull case on quality is airtight: 44.7% ROE, mid-50s gross margins heading higher, a monopoly asset, and multi-year demand visibility now backed by capacity commitments. Companies like this deserve a premium multiple. The honest question is how much premium.

At ~$1,760 the ADR trades near ~50x forward earnings. On the raised guide (~€44B revenue midpoint, ~+20% YoY, 54–56% GM), 2026 EPS lands around €30, with 2027 estimates likely to be revised up as the +30% capacity ramp flows through. Street price targets bracket the debate:

My fair-value estimate: I split the difference and anchor fair value at ~44–46x forward, ≈ $1,850–1,950 near-term, with the business's growth pulling that to $2,000+ over 6–12 months as 2027 numbers rise. That means I am not a buyer chasing $1,850 today — the reward there is thin. But every pullback into the $1,650–1,760 band is a gift, because you're paying a market-mood discount for a franchise whose demand just got more visible, not less.

5. Competitive Position & the China Wildcard

Competitively there is no contest — ASML has no EUV peer, and its DUV immersion tools still dominate the trailing-edge. The real swing factor is geopolitics, specifically China and the pending U.S. MATCH Act.

• China mix is shrinking by design: 19% of system sales in Q1 → 14% in Q2, guided ~20% for the full year. South Korea is now the largest market at 43% of Q2 sales — a healthy pivot toward leading-edge AI demand and away from politically exposed China revenue.
• The MATCH Act would cut off DUV sales and servicing to Chinese chipmakers — roughly a fifth of 2026 revenue at risk. It has cleared committee but not full Congress. This is the single cleanest invalidation trigger for the thesis: passage with a servicing ban would force a numbers reset.
• Counterintuitive near-term effect: Morningstar notes prior restriction threats have pulled forward Chinese demand as customers stockpile ahead of curbs — a short-term tailwind, long-term risk.

6. Technicals

• Resistance: $1,850 (today's intraday high / fresh all-time high). A daily close above it, holding, is the momentum-add trigger and opens a measured move toward $2,000.
• Support: $1,700 (round-number / breakout retest), $1,660 (prior accumulation floor), $1,620 = line in the sand (daily close below = thesis broken).
• Momentum: +115% YTD, RSI stretched into the print; today's reversal off $1,850 is a classic exhaustion candle. Healthy for a stock this extended — a consolidation between $1,660–1,850 would set up the next leg, not threaten it.

7. Three-Scenario Framework (6–12 months)

8. The Actionable Call

The bigger, contrarian takeaway

ASML is the safer way to own the AI-capex theme than the memory names getting crushed around it. Micron (−8.2% today) and the memory complex are exposed to a pricing/supply reflexivity — every new SK Hynix or Samsung fab is a threat to their margins. ASML has the inverse exposure: every new fab, from every competitor, is a customer. On a day when the market punished the memory war's participants, it should have rewarded the arms dealer. It didn't — and that mispricing is the trade.

Scorecard callbacks (prior open calls)

• ASML LONG (HIGH CONV, opened 6/24 @ accumulate $1,660–1,740): CONFIRMED and strengthened. The July 15 print was the binary catalyst — guide raised, not cut; bookings commentary "extremely strong." Thesis intact, reaffirmed.
• MU BUY (HIGH CONV): UNDER PRESSURE / being tested. Down −8.2% today to $902 on the SK Hynix memory-supply scare. Still above the weekly-close stop at $840, but I'll be honest: the memory-supply reflexivity is the live risk to this call, and ASML's read-through helps the equipment layer more than the memory layer. Holding the call, respecting the $840 weekly-close invalidation.
• NVDA BUY (HIGH CONV, $198–206): WORKING — $208.63, −1.5% today, still in/just above the entry band.